c-Src, the

cellular prototype

c-Src, the

cellular prototype Proteasome assay of this kinase family, has been originally discovered as the mammalian homologue of viral Src kinase encoded by the Rous sarcoma virus.18, 19 c-Src is ubiquitously expressed and is of particular importance for governing cellular processes associated with cellular proliferation, differentiation, and cell survival such as cell cycle control, protein synthesis, organization of the cytoskeleton, and the cell adhesion network.6, 7 The present study provides evidence that c-Src contributes toward maintenance of HCV replication, as suppression of c-Src expression by specific siRNAs resulted in an effective down-regulation of HCV replication (Fig. 2). Neither Fyn nor Yes was able to annihilate this inhibitory effect of c-Src knockdown on HCV replication.

This suggests that c-Src plays a specific role for HCV replication and cannot be substituted by the two other ubiquitously expressed SFK members Yes and Fyn, a notion that is further supported by the fact that siRNA directed against these two kinases has no influence on HCV replication. In line with this, HCV replication is also highly sensitive toward the protein tyrosine kinase inhibitor herbimycin A (Fig. 1), which has been originally described as an inhibitor of viral Src activity14 and Tyrosine Kinase Inhibitor Library ic50 subsequently demonstrated to likewise inhibit c-Src activity.13, 15 Our notion that this effect of herbimycin A on HCV replication is indeed mainly due to the inhibition of c-Src function is further supported by the observation that Tolmetin down-regulation of c-Src expression by siRNA is accompanied by a reduction of the IC50 of herbimycin A, which is commensurate to the reduction of c-Src protein levels (Fig. 2D). It has been demonstrated in previous reports that HCV-encoded proteins interact with members of the Src family kinases. Notably, NS5A has been suggested to interact with the SH3 domain of Hck,

Lck, Lyn, and Fyn, but interestingly not with that of c-Src.8, 20 The interaction of NS5A with the respective member of the SFK family was suggested to inhibit the activity of Hck, Lck, and Lyn and enhances activation of Fyn, which in turn resulted in an increased activation of STAT3.8 In contrast to this, a recent report used an siRNA-based screening approach and identified the C-terminal Src kinase, which mediates phosphorylation of the C-terminal inhibitory tyrosine residue of SFKs, to be required for replication. This effect of C-terminal Src kinase was suggested to be due to negative regulation of Fyn,9 because siRNA-mediated suppression of Fyn expression was reported to enhance replication, whereas siRNAs directed against the other ubiquitously expressed SFKs c-Src and Yes were reported to have no effect on replication. In the present study, we were unable to confirm the proposed inhibitory effect of Fyn on HCV replication.

Comments are closed.